Reference
Chen Y-D, et al. Efficacy and safety of the dose-adjusted R-MAD regimen in the treatment of elderly primary central nervous system lymphoma patients. [Chinese]. Chinese Journal of Cancer Prevention and Treatment 28: 1573-1577, No. 20, Oct 2021. Available from: URL: http://kns.cnki.net/kcms/detail/detail.aspx?doi=10.16073/j.cnki.cjcpt.2021.20.10 [Chinese; summarised from a translation]
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1962, 44 (2023). https://doi.org/10.1007/s40278-023-41714-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-41714-4